Skip to main content
. 2019 Jun 28;5(6):FSO398. doi: 10.2144/fsoa-2019-0026

Figure 2. . Role of biomarkers in the development of therapies for Friedreich’s ataxia.

Figure 2. 

Biomarkers are in development for many different contexts of use in FA.

CKC: Corticokinematic coherence; crCEST: Creatine chemical exchange saturation transfer; FARS: Friedreich’s Ataxia Rating Scale; FXN: Frataxin; NFL: Neurofilament light; mRNA: Messenger ribonucleic acid; QST: Quantitative sensory testing; SARA: Scale for assessment and rating of ataxia.